Cardiac amyloidosis: A case report and review of literature

被引:13
作者
Taiwo, Adeyemi Adedamola [1 ]
Alapati, Lavanya [2 ]
Movahed, Assad [2 ]
机构
[1] East Carolina Univ, Dept Internal Med, Greenville, NC 27834 USA
[2] East Carolina Univ, East Carolina Heart Inst, Dept Cardiovasc Sci, 115 Heart Dr, Greenville, NC 27834 USA
关键词
Cardiac amyloidosis; Restrictive cardiomyopathy; Transthyretin; Case report; LIGHT-CHAIN AMYLOIDOSIS; AL AMYLOIDOSIS; WILD-TYPE; MAGNETIC-RESONANCE; IMPROVED OUTCOMES; TRANSTHYRETIN; DIAGNOSIS; TRANSPLANTATION; PATHOPHYSIOLOGY; SCINTIGRAPHY;
D O I
10.12998/wjcc.v7.i6.742
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Cardiac amyloidosis, a disease caused by the precipitation of amyloid proteins in the myocardial extracellular matrix has been historically difficult to diagnose due to lack of specific clinical manifestations and necessity of biopsy to demonstrate amyloid deposition. However, advances in cardiovascular imaging techniques have facilitated earlier recognition of this disease. In addition, while once thought of as incurable, treatment strategies are emerging for cardiac amyloidosis, making early diagnosis essential. CASE SUMMARY We outline the case of a 73 years old African American female who was admitted with sudden onset shortness of breath and found to be in cardiogenic shock. Cardiac amyloidosis was suspected due to discordance between electrocardiogram and echocardiogram findings and this was subsequently confirmed with the aid of scintigraphy and an endomyocardial biopsy. CONCLUSION Our objective is to highlight the diagnostic evaluation and clinical implications of cardiac amyloidosis.
引用
收藏
页码:742 / 752
页数:11
相关论文
共 50 条
  • [1] Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
    Adams, D.
    Gonzalez-Duarte, A.
    O'Riordan, W. D.
    Yang, C. -C.
    Ueda, M.
    Kristen, A. V.
    Tournev, I.
    Schmidt, H. H.
    Coelho, T.
    Berk, J. L.
    Lin, K. -P.
    Vita, G.
    Attarian, S.
    Plante-Bordeneuve, V.
    Mezei, M. M.
    Campistol, J. M.
    Buades, J.
    Brannagan, T. H., III
    Kim, B. J.
    Oh, J.
    Parman, Y.
    Sekijima, Y.
    Hawkins, P. N.
    Solomon, S. D.
    Polydefkis, M.
    Dyck, P. J.
    Gandhi, P. J.
    Goyal, S.
    Chen, J.
    Strahs, A. L.
    Nochur, S. V.
    Sweetser, M. T.
    Garg, P. P.
    Vaishnaw, A. K.
    Gollob, J. A.
    Suhr, O. B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) : 11 - 21
  • [2] Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
    Agha, Ali M.
    Parwani, Purvi
    Guha, Avirup
    Durand, Jean B.
    Iliescu, Cezar A.
    Hassan, Saamir
    Palaskas, Nicolas L.
    Gladish, Greg
    Kim, Peter Y.
    Lopez-Mattei, Juan
    [J]. OPEN HEART, 2018, 5 (02):
  • [3] Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial
    Berk, John L.
    Suhr, Ole B.
    Obici, Laura
    Sekijima, Yoshiki
    Zeldenrust, Steven R.
    Yamashita, Taro
    Heneghan, Michael A.
    Gorevic, Peter D.
    Litchy, William J.
    Wiesman, Janice F.
    Nordh, Erik
    Corato, Manuel
    Lozza, Alessandro
    Cortese, Andrea
    Robinson-Papp, Jessica
    Colton, Theodore
    Rybin, Denis V.
    Bisbee, Alice B.
    Ando, Yukio
    Ikeda, Shu-ichi
    Seldin, David C.
    Merlini, Giampaolo
    Skinner, Martha
    Kelly, Jeffery W.
    Dyck, Peter J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (24): : 2658 - 2667
  • [4] Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions
    Bhogal, Sukhdeep
    Ladia, Vatsal
    Sitwala, Puja
    Cook, Emilie
    Bajaj, Kailash
    Ramu, Vijay
    Lavie, Carl J.
    Paul, Timir K.
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2018, 43 (01) : 10 - 34
  • [5] 99mTc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses
    Bokhari, Sabahat
    Castano, Adam
    Pozniakoff, Ted
    Deslisle, Susan
    Latif, Farhana
    Maurer, Mathew S.
    [J]. CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (02) : 195 - 201
  • [6] LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis
    Boynton, Samuel J.
    Geske, Jeffrey B.
    Dispenzieri, Angela
    Syed, Imran S.
    Hanson, Theodore J.
    Grogan, Martha
    Araoz, Philip A.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2016, 9 (06) : 680 - 686
  • [7] Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress
    Brenner, DA
    Jain, M
    Pimentel, DR
    Wang, B
    Connors, LH
    Skinner, M
    Apstein, CS
    Liao, RL
    [J]. CIRCULATION RESEARCH, 2004, 94 (08) : 1008 - 1010
  • [8] Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models
    Cardoso, Isabel
    Martins, Diana
    Ribeiro, Tania
    Merlini, Giampaolo
    Saraiva, Maria Joao
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [9] The Findings of Electrocardiography in Patients with Cardiac Amyloidosis
    Cheng, Zhongwei
    Zhu, Kongbo
    Tian, Zhuang
    Zhao, Dachun
    Cui, Quancai
    Fang, Quan
    [J]. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2013, 18 (02) : 157 - 162
  • [10] Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin A Prospective, Observational Cohort Study
    Connors, Lawreen H.
    Sam, Flora
    Skinner, Martha
    Salinaro, Francesco
    Sun, Fangui
    Ruberg, Frederick L.
    Berk, John L.
    Seldin, David C.
    [J]. CIRCULATION, 2016, 133 (03) : 282 - 290